Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 7, 2015; 21(41): 11654-11672
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11654
Published online Nov 7, 2015. doi: 10.3748/wjg.v21.i41.11654
Ref. | Country | Adherence to treatment |
Wu et al[130] | Taiwan | 98.2% concomitant therapy |
95.7% sequential therapy | ||
Greenberg et al[131] | Latin America (Chile, Colombia, Costa Rica, Honduras, Nicaragua, and Mexico ) | 92.2% overall |
93.8% concomitant therapy | ||
93% sequential therapy | ||
89.9% standard therapy | ||
McNicholl et al[132] | Spain | 83% concomitant therapy |
82% sequential therapy | ||
Lim et al[133] | South Korea | 96.2% concomitant therapy |
95.3% sequential therapy | ||
Huang et al[134] | Taiwan | 94% concomitant therapy |
95.3% sequential therapy | ||
Hsu et al[135] | Taiwan | 100% concomitant therapy |
98% sequential therapy | ||
99% standard therapy |
-
Citation: Sokic-Milutinovic A, Alempijevic T, Milosavljevic T. Role of
Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol 2015; 21(41): 11654-11672 - URL: https://www.wjgnet.com/1007-9327/full/v21/i41/11654.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i41.11654